106 related articles for article (PubMed ID: 27362789)
21. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
[TBL] [Abstract][Full Text] [Related]
22. Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family.
Mahdavi M; Davoodi J; Zali MR; Foroumadi A
Biomed Pharmacother; 2011 Jun; 65(3):175-82. PubMed ID: 21565459
[TBL] [Abstract][Full Text] [Related]
23. Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting survivin and XIAP.
Fan L; Sun G; Ma T; Zhong F; Wei W
J Pineal Res; 2013 Sep; 55(2):174-83. PubMed ID: 23679681
[TBL] [Abstract][Full Text] [Related]
24. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.
Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL
Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281
[TBL] [Abstract][Full Text] [Related]
25. Effect on apoptosis and cell cycle of recombinant double negative dominant mutation Survivin (T34/117A) in breast cancer cell B-Cap-37.
Wang L; Kang Y; Zheng W; Li L; Shi L; Ma X
Biomed Pharmacother; 2014 Apr; 68(3):277-84. PubMed ID: 24513056
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of a human nanobody against VEGFR-2.
Ma L; Gu K; Zhang CH; Chen XT; Jiang Y; Melcher K; Zhang J; Wang M; Xu HE
Acta Pharmacol Sin; 2016 Jun; 37(6):857-64. PubMed ID: 27108602
[TBL] [Abstract][Full Text] [Related]
27. [Survivin antisense oligonucleotide induces human Hep-2 cell apoptosis].
Liu Y; Yu LL; Cui YH; Ji YX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Aug; 40(8):571-4. PubMed ID: 16270871
[TBL] [Abstract][Full Text] [Related]
28. Screening and identification of a specific peptide for targeting hypoxic hepatoma cells.
Liu Y; Xia X; Wang Y; Li X; Zhou G; Liang H; Feng G; Zheng C
Mol Cell Probes; 2016 Aug; 30(4):246-253. PubMed ID: 27381416
[TBL] [Abstract][Full Text] [Related]
29. A new survivin tracer tracks, delocalizes and captures endogenous survivin at different subcellular locations and in distinct organelles.
Beghein E; Van Audenhove I; Zwaenepoel O; Verhelle A; De Ganck A; Gettemans J
Sci Rep; 2016 Aug; 6():31177. PubMed ID: 27514728
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody.
Kazemi-Lomedasht F; Behdani M; Bagheri KP; Habibi-Anbouhi M; Abolhassani M; Arezumand R; Shahbazzadeh D; Mirzahoseini H
Mol Immunol; 2015 May; 65(1):58-67. PubMed ID: 25645505
[TBL] [Abstract][Full Text] [Related]
31. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
[TBL] [Abstract][Full Text] [Related]
32. PolyI:C and mouse survivin artificially embedding human 2B peptide induce a CD4+ T cell response to autologous survivin in HLA-A*2402 transgenic mice.
Kasamatsu J; Takahashi S; Azuma M; Matsumoto M; Morii-Sakai A; Imamura M; Teshima T; Takahashi A; Hirohashi Y; Torigoe T; Sato N; Seya T
Immunobiology; 2015 Jan; 220(1):74-82. PubMed ID: 25257859
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
[TBL] [Abstract][Full Text] [Related]
34. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
Bi Y; Zhang Y; Cui C; Ren L; Jiang X
Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
[TBL] [Abstract][Full Text] [Related]
35. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
36. Basic fibroblast growth factor upregulates survivin expression in hepatocellular carcinoma cells via a protein kinase B-dependent pathway.
Sun B; Xu H; Zhang G; Zhu Y; Sun H; Hou G
Oncol Rep; 2013 Jul; 30(1):385-90. PubMed ID: 23677479
[TBL] [Abstract][Full Text] [Related]
37. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
38. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
[TBL] [Abstract][Full Text] [Related]
39. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
40. Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells.
Hung CS; Liu HH; Huang MT; Cheng CW; Kuo LJ; Ho YS; Wu CH; Chen CM; Wei PL; Chang YJ
Ann Surg Oncol; 2012 Oct; 19(11):3547-55. PubMed ID: 22711176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
